5 results
8-K
EX-3.1
MLTX
MoonLake Immunotherapeutics - Ordinary Shares
11 Apr 22
Entry into a Material Definitive Agreement
4:40pm
8-K
EX-3.1
MLTX
MoonLake Immunotherapeutics - Ordinary Shares
22 Oct 20
Helix Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering
5:06pm
- Prev
- 1
- Next